1. In: Proceedings of the 4th International Workshop-Conference on Gestational Diabetes Mellitus; Chicago, Illinois, USA. 14-16 March 1997; Diabetes Care 1998;21(Suppl 2):pp B1-167.
2. Lawrence JM, Contreras R, Chen W, Sacks DA. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 2008;31:899-904.
[CROSSREF] [PUBMED]
3. Casagrande SS, Linder B, Cowie CC. Prevalence of gestational diabetes and subsequent type 2 diabetes among U.S. women. Diabetes Res Clin Pract 2018;141:200-8.
[CROSSREF] [PUBMED]
4. Nguyen CL, Pham NM, Binns CW, Duong DV, Lee AH. Prevalence of gestational diabetes mellitus in Eastern and Southeastern Asia: a systematic review and meta-analysis. J Diabetes Res 2018 2018:6536974.
[CROSSREF]
5. Damm P. Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Dan Med Bull 1998;45:495-509.
[PUBMED]
6. Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med 1999;341:1749-56.
[CROSSREF] [PUBMED]
7. Jang HC. Gestational diabetes in Korea: incidence and risk factors of diabetes in women with previous gestational diabetes. Diabetes Metab J 2011;35:1-7.
[CROSSREF] [PUBMED] [PMC]
8. Swarbrick MM, Havel PJ. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 2008;6:87-102.
[CROSSREF] [PUBMED] [PMC]
9. Tun NN, Arunagirinathan G, Munshi SK, Pappachan JM. Diabetes mellitus and stroke: a clinical update. World J Diabetes 2017;8:235-48.
[CROSSREF] [PUBMED] [PMC]
10. Shibata R, Ouchi N, Ohashi K, Murohara T. The role of adipokines in cardiovascular disease. J Cardiol 2017;70:329-34.
[CROSSREF] [PUBMED]
11. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1988;67:341-7.
[CROSSREF] [PUBMED]
12. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 1991;165(6 Pt 1):1667-72.
[CROSSREF] [PUBMED]
13. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004;27:799-800.
[CROSSREF] [PUBMED]
14. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004;89:2306-11.
[CROSSREF] [PUBMED]
15. Vitoratos N, Valsamakis G, Mastorakos G, Boutsiadis A, Salakos N, Kouskouni E, et al. Pre- and early post-partum adiponectin and interleukin-1beta levels in women with and without gestational diabetes. Hormones (Athens) 2008;7:230-6.
[CROSSREF] [PUBMED]
16. Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia 2010;53:268-76.
[CROSSREF] [PUBMED]
17. Retnakaran R, Connelly PW, Maguire G, Sermer M, Zinman B, Hanley AJ. Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of type 2 diabetes. Diabet Med 2007;24:245-52.
[CROSSREF] [PUBMED]
18. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-62.
[CROSSREF] [PUBMED]
19. Choi SH, Kwak SH, Youn BS, Lim S, Park YJ, Lee H, et al. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2008;93:3142-8.
[CROSSREF]
20. Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 2008;22:1416-26.
[CROSSREF]
21. Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007;53:34-41.
[CROSSREF] [PUBMED]
22. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007;148:4687-94.
[CROSSREF] [PUBMED]
23. Saucedo R, Zarate A, Basurto L, Hernandez M, Puello E, Galvan R, et al. Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Arch Med Res 2011;42:318-23.
[CROSSREF] [PUBMED]
24. Jang HC, Cho NH, Jung KB, Oh KS, Dooley SL, Metzger BE. Screening for gestational diabetes mellitus in Korea. Int J Gynaecol Obstet 1995;51:115-22.
[CROSSREF] [PUBMED]
25. Kwak SH, Kim HS, Choi SH, Lim S, Cho YM, Park KS, et al. Subsequent pregnancy after gestational diabetes mellitus: frequency and risk factors for recurrence in Korean women. Diabetes Care 2008;31:1867-71.
[CROSSREF] [PUBMED] [PMC]
26. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes. 2020. Diabetes Care 2020;43(Suppl 1):S14-31.
[PUBMED]
27. Metzger BE. Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes 1991;40(Suppl 2):197-201.
[CROSSREF]
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
[CROSSREF] [PUBMED]
29. Vache C, Rousset P, Gachon P, Gachon AM, Morio B, Boulier A, et al. Bioelectrical impedance analysis measurements of total body water and extracellular water in healthy elderly subjects. Int J Obes Relat Metab Disord 1998;22:537-43.
[CROSSREF] [PUBMED]
30. Skvarca A, Tomazic M, Blagus R, Krhin B, Janez A. Adiponectin/leptin ratio and insulin resistance in pregnancy. J Int Med Res 2013;41:123-8.
[CROSSREF] [PUBMED]
31. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004;279:12152-62.
[CROSSREF] [PUBMED]
32. Al-Badri MR, Zantout MS, Azar ST. The role of adipokines in gestational diabetes mellitus. Ther Adv Endocrinol Metab 2015;6:103-8.
[CROSSREF] [PUBMED] [PMC]
33. O’Sullivan JB. Establishing criteria for gestational diabetes. Diabetes Care 1980;3:437-9.
[CROSSREF] [PUBMED]
34. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773-9.
[CROSSREF] [PUBMED]
35. Vrachnis N, Belitsos P, Sifakis S, Dafopoulos K, Siristatidis C, Pappa KI, et al. Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus. Int J Endocrinol 2012 2012:549748.
[CROSSREF]
36. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116:1784-92.
[CROSSREF] [PUBMED] [PMC]
37. Koh SJ, Hyun YJ, Choi SY, Chae JS, Kim JY, Park S, et al. Influence of age and visceral fat area on plasma adiponectin concentrations in women with normal glucose tolerance. Clin Chim Acta 2008;389:45-50.
[CROSSREF] [PUBMED]
38. Kishida K, Kim KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I. Relationships between circulating adiponectin levels and fat distribution in obese subjects. J Atheroscler Thromb 2011;18:592-5.
[CROSSREF] [PUBMED]
39. Lewandowski KC, Stojanovic N, Bienkiewicz M, Tan BK, Prelevic GM, Press M, et al. Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1). Gynecol Endocrinol 2008;24:300-5.
[CROSSREF] [PUBMED]
40. Tepper BJ, Kim YK, Shete V, Shabrova E, Quadro L. Serum retinol-binding protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes. Clin Biochem 2010;43:320-3.
[CROSSREF] [PUBMED]
41. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-8.
[CROSSREF]